Document ID: chunk:federal_register_of_legislation:F2024C01086:clause:1_15908
Version: federal_register_of_legislation:F2024C01086
Segment Type: clause
Provision Reference: sch 1 cl 15908
Character Range: 924077–926549

15908                                                 Megavoltage planning—level 2.2                                                                                                                                                                                                                                                                                                           2,649.25
                                                      Three‑dimensional radiation therapy simulation and dosimetry for treatment planning with motion management, if:
                                                      (a) all of the following apply in relation to the simulation:
                                                      (i) treatment set‑up and technique specifications are in preparation for complex three‑dimensional planning with consideration of motion management;
                                                      (ii) patient set‑up and immobilisation techniques are reproducible for treatment;
                                                      (iii) a high‑quality three‑dimensional or four‑dimensional image volume dataset is acquired in treatment position for the relevant region of interest to be planned and treated with image verification; and
                                                      (b) all of the following apply in relation to the dosimetry:
                                                      (i) the three‑dimensional planning process is required to calculate dose to three‑dimensional volume structures (which must include structures moving with physiologic processes) and requires a dose‑volume histogram to complete the planning process;
                                                      (ii) based on review and assessment by a radiation oncologist, the three‑dimensional planning process is required to optimise the differential between target dose and normal tissue dose;
                                                      (iii) the planning target volume is rendered as a three‑dimensional structure on planning outputs (three‑dimensional plan review, three‑planar sections review or dose‑volume histogram);
                                                      (iv) organs at risk are delineated, and assessment of dose to these structures is derived from full calculation and inclusion in a dose‑volume histogram
                                                      Applicable once per course of treatment